世界の子宮腺筋症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Adenomyosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0093
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、子宮腺筋症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、ホルモン剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・子宮腺筋症治療の市場動向
・企業の競争状況、市場シェア
・子宮腺筋症治療の種類別市場規模（抗炎症薬、ホルモン剤、その他）
・子宮腺筋症治療の用途別市場規模（病院、クリニック、その他）
・子宮腺筋症治療の北米市場規模2016-2027（アメリカ、カナダ）
・子宮腺筋症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・子宮腺筋症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・子宮腺筋症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・子宮腺筋症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer AG、Ferring B.V、Johnson & Johnson、Novartis、Merck、Pfizer、Contura）
・結論

Adenomyosis disorder also known as Endometriosis interna, Adenomyosis uteri, Endometriosis uterine, or Adenomyometritis. Adenomyosis disorder occurs when endometrial tissue of the uterus endometrial cavity to grow into the uterus muscle that damage the uterine wall the uterine wall grow thicker.

Market Analysis and Insights: Global Adenomyosis Treatment Market
The global Adenomyosis Treatment market size is projected to reach US$ 262.7 million by 2026, from US$ 223.2 million in 2019, at a CAGR of 2.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adenomyosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adenomyosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adenomyosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adenomyosis Treatment market.

Global Adenomyosis Treatment Scope and Market Size
Adenomyosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adenomyosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-inflammatory drugs
Hormone medications
Other

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Ferring B.V
Johnson & Johnson
Novartis
Merck
Pfizer
Contura

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenomyosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory drugs
1.2.3 Hormone medications
1.2.4 Other
1.3 Market by Application
1.3.1 Global Adenomyosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adenomyosis Treatment Market Perspective (2016-2027)
2.2 Adenomyosis Treatment Growth Trends by Regions
2.2.1 Adenomyosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adenomyosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Adenomyosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Adenomyosis Treatment Industry Dynamic
2.3.1 Adenomyosis Treatment Market Trends
2.3.2 Adenomyosis Treatment Market Drivers
2.3.3 Adenomyosis Treatment Market Challenges
2.3.4 Adenomyosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adenomyosis Treatment Players by Revenue
3.1.1 Global Top Adenomyosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Adenomyosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Adenomyosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adenomyosis Treatment Revenue
3.4 Global Adenomyosis Treatment Market Concentration Ratio
3.4.1 Global Adenomyosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenomyosis Treatment Revenue in 2020
3.5 Adenomyosis Treatment Key Players Head office and Area Served
3.6 Key Players Adenomyosis Treatment Product Solution and Service
3.7 Date of Enter into Adenomyosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adenomyosis Treatment Breakdown Data by Type
4.1 Global Adenomyosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Adenomyosis Treatment Forecasted Market Size by Type (2022-2027)

5 Adenomyosis Treatment Breakdown Data by Application
5.1 Global Adenomyosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Adenomyosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adenomyosis Treatment Market Size (2016-2027)
6.2 North America Adenomyosis Treatment Market Size by Type
6.2.1 North America Adenomyosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Adenomyosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Adenomyosis Treatment Market Size by Type (2016-2027)
6.3 North America Adenomyosis Treatment Market Size by Application
6.3.1 North America Adenomyosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Adenomyosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Adenomyosis Treatment Market Size by Application (2016-2027)
6.4 North America Adenomyosis Treatment Market Size by Country
6.4.1 North America Adenomyosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Adenomyosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Adenomyosis Treatment Market Size (2016-2027)
7.2 Europe Adenomyosis Treatment Market Size by Type
7.2.1 Europe Adenomyosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Adenomyosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Adenomyosis Treatment Market Size by Type (2016-2027)
7.3 Europe Adenomyosis Treatment Market Size by Application
7.3.1 Europe Adenomyosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Adenomyosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Adenomyosis Treatment Market Size by Application (2016-2027)
7.4 Europe Adenomyosis Treatment Market Size by Country
7.4.1 Europe Adenomyosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Adenomyosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adenomyosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Adenomyosis Treatment Market Size by Type
8.2.1 Asia-Pacific Adenomyosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adenomyosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adenomyosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Adenomyosis Treatment Market Size by Application
8.3.1 Asia-Pacific Adenomyosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adenomyosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adenomyosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Adenomyosis Treatment Market Size by Region
8.4.1 Asia-Pacific Adenomyosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adenomyosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adenomyosis Treatment Market Size (2016-2027)
9.2 Latin America Adenomyosis Treatment Market Size by Type
9.2.1 Latin America Adenomyosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Adenomyosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Adenomyosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Adenomyosis Treatment Market Size by Application
9.3.1 Latin America Adenomyosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Adenomyosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Adenomyosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Adenomyosis Treatment Market Size by Country
9.4.1 Latin America Adenomyosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Adenomyosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adenomyosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Adenomyosis Treatment Market Size by Type
10.2.1 Middle East & Africa Adenomyosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adenomyosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adenomyosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Adenomyosis Treatment Market Size by Application
10.3.1 Middle East & Africa Adenomyosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adenomyosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adenomyosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Adenomyosis Treatment Market Size by Country
10.4.1 Middle East & Africa Adenomyosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adenomyosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Adenomyosis Treatment Introduction
11.1.4 Bayer AG Revenue in Adenomyosis Treatment Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Ferring B.V
11.2.1 Ferring B.V Company Details
11.2.2 Ferring B.V Business Overview
11.2.3 Ferring B.V Adenomyosis Treatment Introduction
11.2.4 Ferring B.V Revenue in Adenomyosis Treatment Business (2016-2021)
11.2.5 Ferring B.V Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Adenomyosis Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Adenomyosis Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Adenomyosis Treatment Introduction
11.4.4 Novartis Revenue in Adenomyosis Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Adenomyosis Treatment Introduction
11.5.4 Merck Revenue in Adenomyosis Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Adenomyosis Treatment Introduction
11.6.4 Pfizer Revenue in Adenomyosis Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Contura
11.7.1 Contura Company Details
11.7.2 Contura Business Overview
11.7.3 Contura Adenomyosis Treatment Introduction
11.7.4 Contura Revenue in Adenomyosis Treatment Business (2016-2021)
11.7.5 Contura Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adenomyosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory drugs
Table 3. Key Players of Hormone medications
Table 4. Key Players of Other
Table 5. Global Adenomyosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adenomyosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Adenomyosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Adenomyosis Treatment Market Share by Regions (2016-2021)
Table 9. Global Adenomyosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Adenomyosis Treatment Market Share by Regions (2022-2027)
Table 11. Adenomyosis Treatment Market Trends
Table 12. Adenomyosis Treatment Market Drivers
Table 13. Adenomyosis Treatment Market Challenges
Table 14. Adenomyosis Treatment Market Restraints
Table 15. Global Adenomyosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Adenomyosis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Adenomyosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adenomyosis Treatment as of 2020)
Table 18. Ranking of Global Top Adenomyosis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Adenomyosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Adenomyosis Treatment Product Solution and Service
Table 22. Date of Enter into Adenomyosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Adenomyosis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Adenomyosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Adenomyosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Adenomyosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Adenomyosis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Adenomyosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Adenomyosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Adenomyosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Adenomyosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Adenomyosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Adenomyosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Adenomyosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Adenomyosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Adenomyosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Adenomyosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Adenomyosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Adenomyosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Adenomyosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Adenomyosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Adenomyosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Adenomyosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Adenomyosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Adenomyosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Adenomyosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Adenomyosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Adenomyosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Adenomyosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Adenomyosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Adenomyosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Adenomyosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Adenomyosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Adenomyosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Adenomyosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer AG Company Details
Table 63. Bayer AG Business Overview
Table 64. Bayer AG Adenomyosis Treatment Product
Table 65. Bayer AG Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 66. Bayer AG Recent Development
Table 67. Ferring B.V Company Details
Table 68. Ferring B.V Business Overview
Table 69. Ferring B.V Adenomyosis Treatment Product
Table 70. Ferring B.V Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 71. Ferring B.V Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Adenomyosis Treatment Product
Table 75. Johnson & Johnson Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Adenomyosis Treatment Product
Table 80. Novartis Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Adenomyosis Treatment Product
Table 85. Merck Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Adenomyosis Treatment Product
Table 90. Pfizer Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Contura Company Details
Table 93. Contura Business Overview
Table 94. Contura Adenomyosis Treatment Product
Table 95. Contura Revenue in Adenomyosis Treatment Business (2016-2021) & (US$ Million)
Table 96. Contura Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenomyosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory drugs Features
Figure 3. Hormone medications Features
Figure 4. Other Features
Figure 5. Global Adenomyosis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Adenomyosis Treatment Report Years Considered
Figure 10. Global Adenomyosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Adenomyosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Adenomyosis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Adenomyosis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Adenomyosis Treatment Market Share by Players in 2020
Figure 15. Global Top Adenomyosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adenomyosis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Adenomyosis Treatment Revenue in 2020
Figure 17. Global Adenomyosis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Adenomyosis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Adenomyosis Treatment Market Share by Type (2016-2027)
Figure 21. North America Adenomyosis Treatment Market Share by Application (2016-2027)
Figure 22. North America Adenomyosis Treatment Market Share by Country (2016-2027)
Figure 23. United States Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adenomyosis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Adenomyosis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Adenomyosis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adenomyosis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Adenomyosis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Adenomyosis Treatment Market Share by Region (2016-2027)
Figure 39. China Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adenomyosis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Adenomyosis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Adenomyosis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adenomyosis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Adenomyosis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Adenomyosis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Adenomyosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer AG Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 59. Ferring B.V Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 64. Contura Revenue Growth Rate in Adenomyosis Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の腺筋症治療市場 2021：企業別、地域別、種類・用途別

Global Adenomyosis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00343 2021年4月 101Pages
当調査資料では、腺筋症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腺筋症治療の種類別市場規模（抗炎症薬、ホルモン薬、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界のアフリカトリパノソーマ症治療市場規模・現状・予測（2021年-2027年）

Global African Trypanosomiasis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0157 2021年4月 95Pages
QYResearch社発行の本調査資料では、アフリカトリパノソーマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MS-08、CBL-0137、AN-5568、GNF-6702、その他）、用途別市場規模（研究センター、病院、クリニック、そ...

世界の腺筋症治療市場 2021：企業別、地域別、種類・用途別 The Adenomyosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…
世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Treatment Market The global Inflammatory Bowel Disease Treatment market size is projected to reach US$ 15660 million by 2026, from US$ 13310 million in 2019, at a CAGR of 2.3% during 2021-2026. With industry-standard accuracy in analysi…
世界の免疫性炎症性疾患治療市場規模・現状・予測（2021年-2027年） Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…